Survival and PSA-markers for mortality and metastasis in nonmetastatic prostate cancer treated with androgen deprivation therapy. Issue 4 (August 2015)

• Record Type: Journal Article
• Authors: Nguyen-Nielsen, Mary; Liede, Alexander; Maegbaek, Merete Lund; Borre, Michael; Harving, Niels; Hernandez, Rohini Khorana; Sørensen, Henrik Toft; Ehrenstein, Vera
• Is Part Of: Cancer epidemiology. Volume 39:Issue 4(2015)
• Page Start: 623
• Page End: 632
• Publication Date: 2015-08
• Subjects: Cancer -- Epidemiology -- Periodicals; Cancer -- Prevention -- Periodicals; Cancer -- Diagnosis -- Periodicals; Carcinogenesis -- Periodicals; 616.994005
• DOI: 10.1016/j.canep.2015.05.008
• Languages: English
• ISSNs: 1877-7821

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">We examined prognosis of patients with ADT-treated nonmetastatic prostate cancer.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Among the 2494 patients, one-fourth developed metastases within 5 years.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">High PSA level and short PSA doubling time predicted mortality and bone metastasis.</p> </list-item> </list> </p> </sec> </abstract>